-
1.
公开(公告)号:EP3469372A1
公开(公告)日:2019-04-17
申请号:EP17736762.0
申请日:2017-06-12
发明人: MUCHA, Krzysztof , PACZEK, Leszek , ZAGOZDZON, Radoslaw , FORONCEWICZ, Bartosz , DADLEZ, Michal , BAKUN, Magdalena , PIWOWARSKI, Jan , PILZYS, Tomas , MARCINKOWSKI, Michal , GARBICZ, Damian , GRZESIUK, Elzbieta , FLORCZAK, Michal
IPC分类号: G01N33/68
-
公开(公告)号:EP3384289A1
公开(公告)日:2018-10-10
申请号:EP16823045.6
申请日:2016-12-01
发明人: GRZESIUK, Elzbieta , PIWOWARSKI, Jan , PILZYS, Tomasz , WISNIOWSKA, Iga , MARCINKOWSKI, Michal , GARBICZ, Damian , LISIK, Wojciech , KOSIERADZKI, Maciej , PACZEK, Leszek , KRASOWSKI, Pawel
IPC分类号: G01N33/561 , G01N33/68
CPC分类号: G01N33/6854 , G01N33/561 , G01N2800/245
摘要: The invention relates to a method of protein analysis in a urine sample, including preparation of the urine sample and protein detection, wherein the step of preparation of the urine sample for analysis includes mixing the sample without centrifugation and protein detection is performed for the whole urine.
-
公开(公告)号:EP4097480A1
公开(公告)日:2022-12-07
申请号:EP20816593.6
申请日:2020-11-10
发明人: MUCHA, Krzysztof , ZAGOZDZON, Radoslaw , FORONCEWICZ, Bartosz , PACZEK, Leszek , MOSZCZUK, Barbara , KRATA, Natalia , CYSEWSKI, Dominik , DOMANSKI, Dominik , DADLEZ, Michal , BURDUKIEWICZ, Michal
IPC分类号: G01N33/68
-
公开(公告)号:EP4097481A1
公开(公告)日:2022-12-07
申请号:EP20816594.4
申请日:2020-11-10
发明人: MUCHA, Krzysztof , ZAGOZDZON, Radoslaw , FORONCEWICZ, Bartosz , PACZEK, Leszek , MOSZCZUK, Barbara , KRATA, Natalia , CYSEWSKI, Dominik , DOMANSKI, Dominik , DADLEZ, Michal , BURDUKIEWICZ, Michal
IPC分类号: G01N33/68
-
公开(公告)号:EP3358355A1
公开(公告)日:2018-08-08
申请号:EP17461508.8
申请日:2017-02-04
发明人: MUCHA, Krzysztof , ZAGOZDZON, Radoslaw , FORONCEWICZ, Bartosz , PACZEK, Leszek , KRATA, Natalia , GALA, Kamila
IPC分类号: G01N33/68 , G01N33/564
CPC分类号: G01N33/6893 , G01N33/564 , G01N2333/908 , G01N2800/347
摘要: The resent invention relates to the use of at least one of 2-Cys-PRDXs selected from a group consisting of PRDX1, PRDX2, PRDX3, PRDX4 and PRDX5 as a biomarker to diagnose, differentiate and/or assess the risk of chronic kidney disease (CDK). Present invention also relates to the method of diagnosis and the method of determining an increased risk of chronic kidney disease (CKD). Present invention also provides a kit suitable for diagnosis and differentiation of chronic kidney disease (CKD) selected from the group comprising lupus nephritis (LN), IgA nephropathy (IgAN) and autosomal-dominant polycystic kidney disease (ADPKD) in a subject.
-
-
-
-